129 related articles for article (PubMed ID: 8678564)
21. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
[TBL] [Abstract][Full Text] [Related]
22. Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis.
Diep CB; Parada LA; Teixeira MR; Eknaes M; Nesland JM; Johansson B; Lothe RA
Genes Chromosomes Cancer; 2003 Feb; 36(2):189-97. PubMed ID: 12508247
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal aberrations in hepatocellular carcinomas: relationship with pathological features.
Zimmermann U; Feneux D; Mathey G; Gayral F; Franco D; Bedossa P
Hepatology; 1997 Dec; 26(6):1492-8. PubMed ID: 9397989
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
25. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
26. Genetic and pathologic significance of 1p, 17p, and 18q aneusomy and the ERBB2 gene in colorectal cancer and related normal colonic mucosa.
Cianciulli A; Cosimelli M; Marzano R; Merola R; Piperno G; Sperduti I; de la Iglesia F; Leonardo G; Graziano F; Mancini R; Guadagni F
Cancer Genet Cytogenet; 2004 May; 151(1):52-9. PubMed ID: 15120910
[TBL] [Abstract][Full Text] [Related]
27. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
Mendelin J; Grayson M; Wallis T; Visscher DW
Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
[TBL] [Abstract][Full Text] [Related]
28. Numerical chromosome alterations in colorectal carcinomas detected by fluorescence in situ hybridization. Relationship to 17p and 18q allelic losses.
Ooi A; Huang CD; Mai M; Nakanishi I
Virchows Arch; 1996 Jul; 428(4-5):243-51. PubMed ID: 8764933
[TBL] [Abstract][Full Text] [Related]
29. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
[TBL] [Abstract][Full Text] [Related]
30. [Combined fluorescence in situ hybridization and cytofluorometric analysis of numerical chromosomal aberrations in squamous cell carcinomas of the tongue].
Nakai S
Nihon Jibiinkoka Gakkai Kaiho; 1996 Jul; 99(7):1026-35. PubMed ID: 8776977
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic aberrations detected by flow cytometry and fluorescence in situ hybridization in colorectal cancers: two cytogenetic pathways in colorectal carcinogenesis.
Sato T; Oga A; Ikeda E; Todoroki T; Furuya T; Sasaki K
Oncology; 1999 Jul; 57(1):63-9. PubMed ID: 10394127
[TBL] [Abstract][Full Text] [Related]
32. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
33. Numerical aberrations of chromosome 8 in gastric cancer detected by fluorescence in situ hybridization.
Panani AD; Ferti AD; Avgerinos A; Raptis SA
Anticancer Res; 2004; 24(1):155-9. PubMed ID: 15015591
[TBL] [Abstract][Full Text] [Related]
34. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
35. Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients.
Diep CB; Teixeira MR; Thorstensen L; Wiig JN; Eknaes M; Nesland JM; Giercksky KE; Johansson B; Lothe RA
Mol Cancer; 2004 Feb; 3():6. PubMed ID: 14977426
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
[TBL] [Abstract][Full Text] [Related]
37. Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma: a FISH and FCM analysis of 20 cases.
Kato A; Kubo K; Kurokawa F; Okita K; Oga A; Murakami T
Dig Dis Sci; 1998 Jan; 43(1):1-7. PubMed ID: 9508509
[TBL] [Abstract][Full Text] [Related]
38. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
39. Relationship of gene expression and chromosomal abnormalities in colorectal cancer.
Tsafrir D; Bacolod M; Selvanayagam Z; Tsafrir I; Shia J; Zeng Z; Liu H; Krier C; Stengel RF; Barany F; Gerald WL; Paty PB; Domany E; Notterman DA
Cancer Res; 2006 Feb; 66(4):2129-37. PubMed ID: 16489013
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
